Clinical Trial Update: Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intravitreal ranibizumab for central serous chorioretinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Vitreous -Retina- Macula Consultants of New York | Conditions: Central Serous Chorioretinopathy | Phase 1 | Status: COMPLETED